Stop using nowDrug recall · FDA · Published March 6, 2014
Pfizer Recalls Effexor XR 150 mg Due to Foreign Tikosyn Capsule
Pfizer recalls specific lots of Effexor XR 150 mg capsules after a pharmacist found a foreign Tikosyn capsule in a bottle. Check your lot numbers and NDCs.
Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.
Take action
Contact the company
📍Recalling firmPfizer Us Pharmaceutical Group235 E 42nd St · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer
Pfizer is recalling approximately 49,847 bottles of Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, because a pharmacist discovered a foreign Tikosyn (dofetilide) capsule inside one of the containers. This Class I recall affects specific lots distributed nationwide and in Puerto Rico before October 2015. The presence of an incorrect medication poses a serious health risk to patients who may inadvertently take it. Read more at govinfonow.com/recall/46207-pfizer-us-pharmaceutical-group-recalls-effexor-xr-venlafaxine-hcl-extended.
“Pfizer Recalls Effexor XR 150 mg Due to Foreign Tikosyn Capsule.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46207-pfizer-us-pharmaceutical-group-recalls-effexor-xr-venlafaxine-hcl-extended. Based on FDA recall #D-1328-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1328-2014%22&limit=1).
The FDA announced on March 6, 2014, that Pfizer Us Pharmaceutical Group is recalling Effexor XR 150 mg capsules due to the presence of foreign Tikosyn capsules. Consumers should stop using the affected product and contact Pfizer for a refund. This Class I recall involves approximately 49,847 bottles distributed nationwide.
A pharmacist reported that a bottle of the recalled capsules contained a single peach-colored capsule identified as Tikosyn (dofetilide). The presence of this foreign medication poses a risk of unintended ingestion by patients taking Effexor XR.
Context
GovInfoNow's records show Pfizer Us Pharmaceutical Group has issued three other recalls since September 4, 2013. On April 16, 2014, the company recalled Pristiq 50mg tablets due to a foreign 100mg tablet found in the bottle. Other recent recalls of similar products include Taro's children's ibuprofen recall on March 2, 2026, and Bionpharma's doxylamine-pyridoxine tablets recall on August 7, 2026.
How to tell if you have this one
Check your bottle for the NDC 0008-0836-21 (30-count) or NDC 0008-0836-22 (90-unit use). Verify the lot number is either V130142 or V130140, with an expiration date of 10/15. The bottles are distributed by Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
Brand
Pfizer
Product
Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop using the medication
Do not take any capsules from the recalled bottles due to the risk of ingesting the foreign Tikosyn capsule.
Contact your pharmacy or doctor
Reach out to your healthcare provider or pharmacist immediately to discuss alternative treatment options and proper disposal.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.2 years after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1328-2014 (March 6, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1328-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.